C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 16/28 (2006.01) A61K 39/395 (2006.01) A61P 9/00 (2006.01) A61P 29/00 (2006.01) A61P 35/00 (2006.01) C12N 15/13 (2006.01) C07K 14/71 (2006.01)
Patent
CA 2694396
The invention relates to targeted binding agents against KDR and uses of such agents. More specifically, the inven-tion relates to fully human monoclonal antibodies directed to KDR. The described targeted binding agents are useful in the treatment of diseases associated with the activity and/or overproduction of KDR and as diagnostics.
La présente invention concerne des agents de liaison ciblés dirigés contre KDR et des utilisations desdits agents. Plus spécifiquement, l'invention concerne des anticorps entièrement humains monoclonaux dirigés vers KDR. Les agents de liaison ciblés ci-décrits sont utiles dans le traitement de maladies associées à l'activité et/ou à la surproduction de KDR. Lesdits agents sont également utiles dans la réalisation de diagnostics.
Barry Simon Thomas
Bedian Vahe
Hedberg Bradley
Kang Jaspal Singh
Zhou Qing
Astrazeneca Ab
Smart & Biggar
LandOfFree
Targeted binding agents directed to kdr and uses thereof - 035 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Targeted binding agents directed to kdr and uses thereof - 035, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Targeted binding agents directed to kdr and uses thereof - 035 will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1603238